Genetic and non-genetic determinants of raltegravir penetration into cerebrospinal fluid: a single arm pharmacokinetic study.
Antiretroviral drugs vary in their central nervous system penetration, with better penetration possibly conferring neurocognitive benefit during human immunodeficiency virus (HIV) therapy. The efflux transporter gene ABCB1 is expressed in the blood-brain barrier, and an ABCB1 variant (3435C → T) has...
Main Authors: | Daniel H Johnson, Deborah Sutherland, Edward P Acosta, Husamettin Erdem, Danielle Richardson, David W Haas |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3859605?pdf=render |
Similar Items
-
Population pharmacokinetics and cerebrospinal fluid penetration of fluconazole in adults with cryptococcal meningitis
by: Stott, K, et al.
Published: (2018) -
HIV resistance to raltegravir
by: Clavel François
Published: (2009-11-01) -
The genetic regulation of protein expression in cerebrospinal fluid
by: Oskar Hansson, et al.
Published: (2023-01-01) -
Cerebrospinal Fluid Penetrance of Daratumumab in Leptomeningeal Multiple Myeloma
by: Marina Zajec, et al.
Published: (2020-08-01) -
Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir
by: Goubau Patrick, et al.
Published: (2010-11-01)